Clinical Trial Update: Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab in combination with galiximab for non-Hodgkin lymphoma has completed, with results not detailed in the provided excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Galiximab (galiximab)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED